FDA Issues Accelerated Approval Draft Guidance for Oncology

The FDA is looking for feedback on its newly published draft guidance on designing cancer drug trials intended for the accelerated approval pathway.
Medscape Medical News

source https://www.medscape.com/viewarticle/990242?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors